52 /100
HIGH RISK
Score updated Jul 13, 2026

CMMB — Chemomab Therapeutics Ltd. Dilution Risk Tracker

Track CMMB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CMMB — Get alerts when the score changes →

As of July 13, 2026, Chemomab Therapeutics Ltd. (CMMB) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Chemomab Therapeutics Ltd. has a market capitalization of $14.40M, 575.38M shares outstanding. Key dilution vectors include approximately 6 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
0
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
33%
🔄 Reverse Split 45%
• 50-day avg $1.69 approaching $1 threshold
• Only 6 months cash — financial pressure
💰 Capital Raise 35%
• Low cash runway: 6 months remaining
🔔 Track CMMB — Get forecast alerts →

💹 Market Data

Market Cap$14.40M
Shares Outstanding575.38M
FloatN/A
Cash$7.56M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

4.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track CMMB for full holder detail →

📉 Short Interest

Short Interest143.1K
Days to Cover4.2
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CMMB Shareholders

Chemomab Therapeutics Ltd. (CMMB) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: CMMB has approximately 6 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for CMMB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CMMB alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CMMB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CMMB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CMMB
📊 CMMB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CMMB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.